Opinion|Videos|January 9, 2024
Optimizing Drug Delivery Methods With Nanotechnologies
Author(s)Ascendia Pharma
Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, highlights the benefits of the company’s nanotechnologies in supporting formulation development of poorly soluble molecules.
Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, discusses:
- Capabilities related to formulation development and manufacturing of cGMP batches
- Considerations in the development of formulations for poorly soluble molecules
- Role of nanotechnologies to optimize drug delivery methods, such as long-acting injectables
Related Content
Trending on Pharmaceutical Technology
1
Putting Sustainability to Work in Pharma
2
Managing Global Trial Supply Risk: Expert Insights
3
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
4
Technology Transfer: Success Drivers and Obstacles Explained
5